T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma-Reference-Cited by-同舟云学术

T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma

Published:2016-11 Issue:9 Volume:39 Page:343-354
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Tähtinen Siri,Blattner Carolin,Vähä-Koskela Markus,Saha Dipongkor,Siurala Mikko,Parviainen Suvi,Utikal Jochen,Kanerva Anna,Umansky Viktor,Hemminki Akseli

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference60 articles.

1. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;N Engl J Med,2013

2. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma;Dudley;J Clin Oncol,2005

3. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens;Dudley;J Clin Oncol,2008

4. Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells;Wang;Cancer Res,2005

5. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy;Rosenberg;Clin Cancer Res,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic Viruses in Cancer Immunotherapy;Advanced Therapeutics;2024-05-22

2. Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial;Clinical Cancer Research;2024-03-27

3. Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy;Anti-Cancer Agents in Medicinal Chemistry;2023-11

4. Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy;Human Gene Therapy;2023-09-01

5. Progress of oncolytic virotherapy for neuroblastoma;Frontiers in Pediatrics;2022-11-18